The Effect of Pregnancy on the Pharmacokinetics of the Kaletra Tablet: A Longitudinal Investigation in the Second and Third Trimesters Including Empiric Dosage Adjustment.

Trial Profile

The Effect of Pregnancy on the Pharmacokinetics of the Kaletra Tablet: A Longitudinal Investigation in the Second and Third Trimesters Including Empiric Dosage Adjustment.

Completed
Phase of Trial: Phase I

Latest Information Update: 12 May 2011

At a glance

  • Drugs Lopinavir/ritonavir (Primary)
  • Indications HIV infections; Pregnancy
  • Focus Pharmacokinetics
  • Most Recent Events

    • 12 May 2011 Status changed from active, no longer recruiting to completed by ClinicalTrials.gov.
    • 12 May 2011 Trial phase changed from IV to I as reported by ClinicalTrials.gov.
    • 12 May 2011 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top